3 jobs found in Basel

Basel 80-100% | immediately or by arrangement We are looking for an experienced Cloud Data Engineer to strategically expand our cloud data platform. The ideal candidate will be well-versed in the Swiss insurance and healthcare sectors. As a Cloud Data Engineer, you will combine your technical expertise with an understanding of business processes and requirements, actively driving the development of our data infrastructure alongside your new team members. Do you have a learning mindset and are you ready to contribute to the continuous development of our cloud technology within an interdisciplinary team? Then apply now and become part of our Data Intelligence team! We offer a diverse and exciting range of tasks, modern employment conditions, and the option of mobile working and working from home. Here's how you can get involved: Developing, implementing, and further developing modern and scalable data solutions in the cloud. Designing end-to-end data...

The Opportunity We are supporting a major   data platform transformation within a banking environment , moving from a legacy SQL Server and SSIS-based setup to a modern, scalable architecture built on   dbt, Dagster, and OpenShift . This role is not about maintaining existing systems. It is about   rebuilding a critical data platform from the ground up , with direct impact on   risk, trading PnL, and core financial data flows . We are looking for a   hands-on Senior Data Engineer   who can take ownership of complex migration workstreams and deliver reliably in a regulated, high-stakes environment. What You Will Do You will play a central role in the   end-to-end migration and modernisation   of the data platform. Platform Transformation Translate legacy ETL logic from SSIS and stored procedures into modern   ELT pipelines using dbt Implement   Data Vault 2.0 structures   including Raw Vault and Business Vault Build   datamarts and curated...

About us GRANITE BIO is a private biotechnology company located in Basel (Switzerland). GRANITE BIO is supported by top-tier investors with ~$100M raised to date. Based on fundamental research conducted over the last two decades, GRANITE BIO’s is pursuing a differentiated approach to transform inflammatory, autoimmune, and fibrotic conditions. Both our programs are first-in-class monoclonal antibodies for large market opportunities in Immunology and Inflammation. GRT-001, the lead asset, depletes inflammatory monocytes. It has just completed a Phase 1a trial in healthy volunteers and has shown favorable safety and pharmacodynamic effect. The Phase 1b trial in patients with Ulcerative Colitis has just started. GRT-002 is an IL-3 neutralizing antibody that is thought to play an important role in type II inflammation. We are seeking a Data Scientist with strong expertise in data transfers (DTS), statistical analysis, and translational data integration to join our Translational...